Quantitative Systematic Strategies LLC Denali Therapeutics Inc. Transaction History

Quantitative Systematic Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$48.48 - $78.23 $208,512 - $336,467	-4,301 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$50.3 - $78.44 $336,959 - $525,469	-6,699 Reduced 60.9%	4,301 $337,000
Q1 2021 May 06, 2021	BUY	$53.8 - $81.53 $428,732 - $649,712	7,969 Added 262.92%	11,000 $628,000
Q4 2020 Feb 09, 2021	SELL	$36.89 - $93.56 $319,946 - $811,445	-8,673 Reduced 74.1%	3,031 $254,000
Q3 2020 Nov 09, 2020	BUY	$23.13 - $38.84 $37,239 - $62,532	1,610 Added 15.95%	11,704 $419,000
Q2 2020 Aug 04, 2020	BUY	$16.01 - $28.82 $161,604 - $290,909	10,094 New	10,094 $244,000

240

121M

80K

36.8K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.01B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.